Newly Approved Drug Ushers In Hopeful Era For Patients Who Experience Debilitating Migraines

The drug will be listed at $6,900 a year and can be injected with a device similar to an insulin pen. While doctors are excited about the new treatment, some warn that it's "progress, but not a panacea."

from Kaiser Health News https://ift.tt/2KBiZNa